Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China flag China · Delayed Price · Currency is CNY
15.93
-0.25 (-1.55%)
Aug 31, 2026, 3:04 PM CST

SHE:002603 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
852.31,105853.03940.511,904995.26
Trading Asset Securities
1,264764.42-205.97518.3855.27
Cash & Short-Term Investments
2,1171,869853.031,1462,4231,051
Cash Growth
32.23%119.14%-25.60%-52.68%130.61%-32.40%
Accounts Receivable
1,8741,6491,3902,5962,1782,361
Other Receivables
18.3516.09130.075.596.544.73
Receivables
1,8931,6651,5202,6022,1842,366
Inventory
1,6021,4891,7462,4592,0221,673
Prepaid Expenses
7.754.6626.0993.90.739.39
Other Current Assets
125.03178.59189.28242.67624.8473.65
Total Current Assets
5,7445,2064,3356,5447,2545,602
Property, Plant & Equipment
6,7256,9477,2537,3116,2295,758
Long-Term Investments
5.65.576.51,6511,3491
Goodwill
100.16103.28109.51115.75--
Other Intangible Assets
928.24791.87802.57743.52724.01660.5
Long-Term Deferred Tax Assets
164.34218.35365.84183.58284.43117
Long-Term Deferred Charges
167.96260.12266.88189.37107.16239.33
Other Long-Term Assets
148.23142.72180.36241.39392.65527.03
Total Assets
13,98413,67513,31916,97916,34112,905

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
1,8421,4681,8972,8472,0611,621
Accrued Expenses
282.76336.31350.83419.64644.78269.71
Short-Term Debt
---600.35500.35702.48
Current Portion of Long-Term Debt
---201.12150.12-
Current Portion of Leases
7.939.698.245.55.8613.43
Current Income Taxes Payable
16.0736.8623.4642.45242.1511.38
Current Unearned Revenue
360.3305.76272.34287.521,106301.56
Other Current Liabilities
97.751.3155.2643.58140.3540.7
Total Current Liabilities
2,6072,2082,6074,4474,8502,960
Long-Term Debt
---599.1200.15500.47
Long-Term Leases
14.3616.0418.2113.0114.9712.53
Long-Term Unearned Revenue
353.69359.75377.92352.37335.02357.84
Long-Term Deferred Tax Liabilities
105.49109.11114.25130.1410.241.39
Total Liabilities
3,0812,6933,1175,5415,4113,833

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,6711,6711,6711,6711,6711,671
Additional Paid-In Capital
2,3242,3242,3432,3432,3432,343
Retained Earnings
6,9247,0026,2177,4436,9265,065
Comprehensive Income & Other
-8.13-7.83-7.12-6.61-7.22-9.71
Total Common Equity
10,91110,98910,22311,45010,9329,069
Minority Interest
-7.43-7.21-21.4-11.73-1.953.04
Shareholders' Equity
10,90310,98210,20211,43810,9309,072
Total Liabilities & Equity
13,98413,67513,31916,97916,34112,905

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
22.2925.7426.451,419871.451,229
Net Cash (Debt)
2,0941,844826.58-272.61,551-178.37
Net Cash Growth
33.47%123.04%----
Net Cash Per Share
1.251.100.49-0.160.93-0.11
Filing Date Shares Outstanding
1,6711,6711,6711,6711,6711,671
Total Common Shares Outstanding
1,6711,6711,6711,6711,6711,671
Working Capital
3,1372,9981,7282,0972,4042,642
Book Value Per Share
6.536.586.126.856.545.43
Tangible Book Value
9,88210,0949,31110,59010,2088,409
Tangible Book Value Per Share
5.926.045.576.346.115.03
Buildings
5,9875,9335,6685,4074,3533,620
Machinery
3,8953,8763,5813,0982,4842,005
Construction In Progress
883.09890.661,1971,4711,5741,950